Jacobi Capital Management LLC Trevena Inc Transaction History

Jacobi Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.2 - $0.5 $3,100 - $7,750	-15,500 Reduced 43.66%	20,000 $8,000
Q1 2022 May 06, 2022	BUY	$0.41 - $0.63 $2,050 - $3,150	5,000 Added 16.39%	35,500 $20,000
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $8,835 - $19,995	15,500 Added 103.33%	30,500 $18,000
Q2 2021 Aug 12, 2021	SELL	$1.46 - $2.25 $14,162 - $21,825	-9,700 Reduced 39.27%	15,000 $25,000
Q1 2021 May 11, 2021	SELL	$1.77 - $2.93 $531 - $879	-300 Reduced 1.2%	24,700 $44,000
Q3 2020 Oct 30, 2020	BUY	$1.53 - $3.13 $30,600 - $62,600	20,000 Added 400.0%	25,000 $75,000
Q2 2020 Aug 04, 2020	BUY	$0.48 - $1.75 $2,296 - $8,373	4,785 Added 2225.58%	5,000 $8,000
Q2 2020 Jul 27, 2020	BUY	$0.48 - $1.75 $103 - $376	215 New	215 $8,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.